CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Alvogen Korea Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Alvogen Korea Co., Ltd.
13F, Two IFC Dong
Seoul International Finance Center
Phone: +82 220477700p:+82 220477700 Seoul, 07326  South Korea Fax: +82 24430589f:+82 24430589
This company is no longer actively traded on any major stock exchange.
Business Summary
Alvogen Korea Co., Ltd. formerly Kun Wha Pharmaceutical Co., Ltd., is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company’s products consist of remedies for hyperpotassemia, remedies for hypertension, steroid anti-inflammatory agents, analgesics, penicillins antibiotics, brain improvement agents, remedies for prostatism and others. On June 13, 2013, the Company sold its entire shares of Longstand International Limited, which is mainly engaged in the construction business, as well as GOJIN MOTORS, which is mainly engaged in the vehicle sales and maintenance service.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 IRA CQ
Score		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating		 Morningstar
Rating
-Yes-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201812/31/2018Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Jun SuLee 45 12/12/2018 12/12/2018
Internal Auditor AnaHarradson 46 12/14/2012 12/14/2012
Director Kevin M.Bane 54 12/14/2012 12/14/2012
4 additional Officers and Directors records available in full report.

Business Names
Business Name
002250
Keunwha Pharmaceutical Co., Ltd
KEUNWHA Pharmaceutical Co., Ltd.
Kun Wha
KunWha Pharmaceutical Co., Ltd.

General Information
Number of Employees: 605 (As of 12/31/2018)
Outstanding Shares: 11,857,922 (As of 12/31/2018)
Shareholders: 1,574
Stock Exchange: SEO
Fax Number: +82 24430589


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, December 14, 2019